Advertisement

International Cancer Conference Journal

, Volume 8, Issue 1, pp 12–16 | Cite as

Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment

  • Yuzuru SakamotoEmail author
  • Toshiya KamiyamaEmail author
  • Hideki Yokoo
  • Shingo Shimada
  • Takahiro Einama
  • Kenji Wakayama
  • Tatsuya Orimo
  • Hirofumi Kamachi
  • Tomoaki Naka
  • Tomoko Mitsuhashi
  • Akinobu Taketomi
Case report
  • 17 Downloads

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a naturally occurring glycoprotein that is synthesized by stromal cells in bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but it is extremely rare in hepatocellular carcinoma (HCC). Here, we report a rare case of HCC producing G-CSF. The patient presented with a continuous fever and had a huge liver mass in the right lobe with portal vein tumor thrombus (PVTT) in the right first branch. He had marked granulocytosis, and his serum level of G-CSF was elevated. A complete curative liver resection was performed after preoperative radiotherapy to PVTT. The pathological findings of the resected specimen revealed poorly/moderately differentiated HCC, and immunohistochemical staining of G-CSF was negative the first time it was tested, but the second time, it was positive in the cytoplasm of other tumor cells of HCC. Only a few cases of G-CSF-producing HCC have been reported, and they resulted in rapid tumor growth, metastases, and poor prognosis. In our case with PVTT, there was no liver recurrence, although multiple lung metastases occurred at 8 months after curative resection. We should consider G-CSF-producing HCC and diagnose promptly when encountering liver tumor patients with leukocytosis, and we should perform multimodal treatment including radiation, radical surgery, and chemotherapy.

Keywords

G-CSF-producing tumor Hepatocellular carcinoma Radical surgery Immunohistochemistry Chemotherapy 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study is approved by the ethics committee of Hokkaido University Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient.

References

  1. 1.
    Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28–35CrossRefGoogle Scholar
  2. 2.
    Asano S, Urabe A, Okabe T et al (1977) Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 49:845–852Google Scholar
  3. 3.
    Iwasa K, Noguchi M, Mor K et al (1995) Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today 25:158–160CrossRefGoogle Scholar
  4. 4.
    Ito N, Matsuda T, Kakehi Y et al (1990) Bladder cancer producing granulocyte colony-stimulating factor. N Engl J Med 323:1709–1710Google Scholar
  5. 5.
    Furihata M, Sonobe H, Ohtsuki Y et al (1999) An immunohistochemical study on a case of granulocyte-colony stimulating factor-producing gall-bladder carcinoma. Pathol Int 49:1010–1013CrossRefGoogle Scholar
  6. 6.
    Endo K, Kohnoe S, Okamura T et al (2005) Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer 8:173–177CrossRefGoogle Scholar
  7. 7.
    Kamiyama T, Nakanishi K, Yokoo H et al (2007) Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 12:363–368CrossRefGoogle Scholar
  8. 8.
    Ueno M, Seferynska I, Beckman B et al (1989) Enhanced erythropoietin secretion in hepatoblastoma cells in response to hypoxia. Am J Physiol 257:C743–C749CrossRefGoogle Scholar
  9. 9.
    Tani K, Ozawa K, Ogura H et al (1990) Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 3:325–331CrossRefGoogle Scholar
  10. 10.
    Aita K, Seki K (2006) Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 56:413–419CrossRefGoogle Scholar
  11. 11.
    Joshita S, Nakazawa K, Koike S et al (2010) A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci 25:476–480CrossRefGoogle Scholar
  12. 12.
    Berdel WE, Danhauser-Riedl S, Steinhauser G et al (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80–83Google Scholar
  13. 13.
    Yamamoto S, Takashima S, Ogawa H et al (1999) Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol 34:640–644CrossRefGoogle Scholar
  14. 14.
    Ito T, Okubo K, Shiomi M et al (2012) [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur–uracil.]. Nihon Shokakibyo Gakkai Zasshi 109:2088–2096Google Scholar
  15. 15.
    Amano H, Itamoto T, Emoto K et al (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159CrossRefGoogle Scholar
  16. 16.
    Araki K, Kishihara F, Takahashi K et al (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27:716–721CrossRefGoogle Scholar
  17. 17.
    Kohno M, Shirabe K, Mano Y et al (2013) Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today 43:439–445CrossRefGoogle Scholar
  18. 18.
    Snyder RA, Liu E, Merchant NB (2012) Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg 78:821–822Google Scholar
  19. 19.
    Nagata H, Komatsu S, Takaki W et al (2016) Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol 7:380–386CrossRefGoogle Scholar

Copyright information

© The Japan Society of Clinical Oncology 2018

Authors and Affiliations

  • Yuzuru Sakamoto
    • 1
    Email author
  • Toshiya Kamiyama
    • 1
    Email author
  • Hideki Yokoo
    • 1
  • Shingo Shimada
    • 1
  • Takahiro Einama
    • 1
  • Kenji Wakayama
    • 1
  • Tatsuya Orimo
    • 1
  • Hirofumi Kamachi
    • 1
  • Tomoaki Naka
    • 2
  • Tomoko Mitsuhashi
    • 2
  • Akinobu Taketomi
    • 1
  1. 1.Department of Gastroenterological Surgery IHokkaido University Graduate School of MedicineSapporoJapan
  2. 2.Department of Surgical PathologyHokkaido University HospitalSapporoJapan

Personalised recommendations